Attomarker

Post operative patient recovery monitoring system based on biochemical readings that ensures patients are released at the right time, thereby freeing up bed occupancy and other resources.

Attomarker Ltd is a spin-out company from the University of Exeter, founded to develop a novel, label-free, array-based technology to monitor concentrations of large numbers of biomarkers in the blood to provide a differential diagnosis of disease to assist the clinical decision makers. Multiple simultaneous biomarker analysis of blood chemistry points to a new direction in diagnosis for complex conditions such as allergy or irritable bowel syndrome, or the recovery of patients from operations. The multi-marker analysis provides a view of the health of a patient, an allergy profile or a novel way to follow the recovery of a patient after a surgical procedure.